382 related articles for article (PubMed ID: 31835273)
21. Bactericidal effects of various concentrations of enrofloxacin, florfenicol, tilmicosin phosphate, and tulathromycin on clinical isolates of Mannheimia haemolytica.
Blondeau JM; Shebelski SD; Hesje CK
Am J Vet Res; 2015 Oct; 76(10):860-8. PubMed ID: 26413823
[TBL] [Abstract][Full Text] [Related]
22. Antimicrobial multidrug resistance and coresistance patterns of Mannheimia haemolytica isolated from bovine respiratory disease cases--a three-year (2009-2011) retrospective analysis.
Lubbers BV; Hanzlicek GA
J Vet Diagn Invest; 2013 May; 25(3):413-7. PubMed ID: 23572456
[TBL] [Abstract][Full Text] [Related]
23. Observations on macrolide resistance and susceptibility testing performance in field isolates collected from clinical bovine respiratory disease cases.
DeDonder KD; Harhay DM; Apley MD; Lubbers BV; Clawson ML; Schuller G; Harhay GP; White BJ; Larson RL; Capik SF; Riviere JE; Kalbfleisch T; Tessman RK
Vet Microbiol; 2016 Aug; 192():186-193. PubMed ID: 27527782
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of multi drug antimicrobial resistance in isolated from high-risk stocker cattle at arrival and two weeks after processing.
Snyder E; Credille B; Berghaus R; Giguère S
J Anim Sci; 2017 Mar; 95(3):1124-1131. PubMed ID: 28380515
[TBL] [Abstract][Full Text] [Related]
25. Estimating the comparative clinical and economic consequences of tulathromycin for treatment of present or anticipated outbreaks of bovine respiratory disease in feedlot cattle in the United States.
Nautrup BP; Van Vlaenderen I; Gasper SM; Holland RE
J Anim Sci; 2013 Dec; 91(12):5868-77. PubMed ID: 24126273
[TBL] [Abstract][Full Text] [Related]
26. Characterization of Mannheimia haemolytica isolated from feedlot cattle that were healthy or treated for bovine respiratory disease.
Klima CL; Alexander TW; Hendrick S; McAllister TA
Can J Vet Res; 2014 Jan; 78(1):38-45. PubMed ID: 24396179
[TBL] [Abstract][Full Text] [Related]
27. Essential oils inhibit the bovine respiratory pathogens Mannheimia haemolytica, Pasteurella multocida and Histophilus somni and have limited effects on commensal bacteria and turbinate cells in vitro.
Amat S; Baines D; Timsit E; Hallewell J; Alexander TW
J Appl Microbiol; 2019 Jun; 126(6):1668-1682. PubMed ID: 30817050
[TBL] [Abstract][Full Text] [Related]
28. Antimicrobial resistance in
Credille B
Anim Health Res Rev; 2020 Dec; 21(2):196-199. PubMed ID: 33261715
[TBL] [Abstract][Full Text] [Related]
29. A 4-year survey of antimicrobial susceptibility trends for isolates from cattle with bovine respiratory disease in North America.
Watts JL; Yancey RJ; Salmon SA; Case CA
J Clin Microbiol; 1994 Mar; 32(3):725-31. PubMed ID: 8195385
[TBL] [Abstract][Full Text] [Related]
30. Comparison of antemortem antimicrobial treatment regimens to antimicrobial susceptibility patterns of postmortem lung isolates from feedlot cattle with bronchopneumonia.
Lamm CG; Love BC; Krehbiel CR; Johnson NJ; Step DL
J Vet Diagn Invest; 2012 Mar; 24(2):277-82. PubMed ID: 22362524
[TBL] [Abstract][Full Text] [Related]
31. [In vitro activity of 12 antibiotics used in veterinary medicine against Mannheimia haemolytica and Pasteurella multocida isolated from calves in the Netherlands].
Mevius DJ; Hartman EG
Tijdschr Diergeneeskd; 2000 Mar; 125(5):147-52. PubMed ID: 10730339
[TBL] [Abstract][Full Text] [Related]
32. Mutant prevention and minimum inhibitory concentration drug values for enrofloxacin, ceftiofur, florfenicol, tilmicosin and tulathromycin tested against swine pathogens Actinobacillus pleuropneumoniae, Pasteurella multocida and Streptococcus suis.
Blondeau JM; Fitch SD
PLoS One; 2019; 14(1):e0210154. PubMed ID: 30629633
[TBL] [Abstract][Full Text] [Related]
33. Agreement of antimicrobial susceptibility testing of Pasteurella multocida and Mannheimia haemolytica isolates from preweaned dairy calves with bovine respiratory disease.
Credille BC; Capik SF; Credille A; Crossley BM; Blanchard P; Woolums AR; Lehenbauer TW
Am J Vet Res; 2023 Nov; 84(11):. PubMed ID: 37558231
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the diagnostic performance of bacterial culture of nasopharyngeal swab and bronchoalveolar lavage fluid samples obtained from calves with bovine respiratory disease.
Capik SF; White BJ; Lubbers BV; Apley MD; DeDonder KD; Larson RL; Harhay GP; Chitko-McKown CG; Harhay DM; Kalbfleisch TS; Schuller G; Clawson ML
Am J Vet Res; 2017 Mar; 78(3):350-358. PubMed ID: 28240958
[TBL] [Abstract][Full Text] [Related]
35. Antimicrobial Susceptibility of Bacteria That Cause Bovine Respiratory Disease Complex in Alberta, Canada.
Anholt RM; Klima C; Allan N; Matheson-Bird H; Schatz C; Ajitkumar P; Otto SJ; Peters D; Schmid K; Olson M; McAllister T; Ralston B
Front Vet Sci; 2017; 4():207. PubMed ID: 29255716
[TBL] [Abstract][Full Text] [Related]
36. Genetic relatedness and antimicrobial resistance in respiratory bacteria from beef calves sampled from spring processing to 40 days after feedlot entry.
Guo Y; McMullen C; Timsit E; Hallewell J; Orsel K; van der Meer F; Yan S; Alexander TW
Vet Microbiol; 2020 Jan; 240():108478. PubMed ID: 31902491
[TBL] [Abstract][Full Text] [Related]
37. Antimicrobial susceptibility monitoring of respiratory tract pathogens isolated from diseased cattle and pigs across Europe: the VetPath study.
de Jong A; Thomas V; Simjee S; Moyaert H; El Garch F; Maher K; Morrissey I; Butty P; Klein U; Marion H; Rigaut D; Vallé M
Vet Microbiol; 2014 Aug; 172(1-2):202-15. PubMed ID: 24837878
[TBL] [Abstract][Full Text] [Related]
38. Accuracy of susceptibility testing of Pasteurella multocida and Mannheimia haemolytica.
Catry B; Dewulf J; de Kruif A; Vanrobaeys M; Haesebrouck F; Decostere A
Microb Drug Resist; 2007; 13(3):204-11. PubMed ID: 17949308
[TBL] [Abstract][Full Text] [Related]
39. Variation in fluoroquinolone pharmacodynamic parameter values among isolates of two bacterial pathogens of bovine respiratory disease.
Wen X; Gehring R; Riviere JE; Lubbers BV; Gaire TN; Wyche B; Fox B; Quichocho V; Volkova VV
Sci Rep; 2018 Jul; 8(1):10553. PubMed ID: 30002424
[TBL] [Abstract][Full Text] [Related]
40. Applying definitions for multidrug resistance, extensive drug resistance and pandrug resistance to clinically significant livestock and companion animal bacterial pathogens.
Sweeney MT; Lubbers BV; Schwarz S; Watts JL
J Antimicrob Chemother; 2018 Jun; 73(6):1460-1463. PubMed ID: 29481657
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
